Donatos Tsamoulis

Elefsina, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry.

Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry.

Journal: Acta cardiologica

Published: July 23, 2026

Treatment disparities and prognosis among myocardial infarction patients without standard modifiable risk factors.

Treatment disparities and prognosis among myocardial infarction patients without standard modifiable risk factors.

Journal: Cardiology

Published: April 15, 2026

Treatment Disparities and Prognosis among Myocardial Infarction Patients without Standard Modifiable Risk Factors.

Treatment Disparities and Prognosis among Myocardial Infarction Patients without Standard Modifiable Risk Factors.

Journal: Cardiology

Published: April 15, 2026

Letter to editor Reply to IPE eligibility post-ACS: Clarifying treatment gaps and refining lipid-based risk assessment.

Letter to editor Reply to IPE eligibility post-ACS: Clarifying treatment gaps and refining lipid-based risk assessment.

Journal: International journal of cardiology

Published: September 07, 2025

Newly diagnosed versus previously diagnosed or no diabetes mellitus in patients with acute coronary syndrome: a systematic review and meta-analysis.

Newly diagnosed versus previously diagnosed or no diabetes mellitus in patients with acute coronary syndrome: a systematic review and meta-analysis.

Journal: Expert review of cardiovascular therapy

Published: June 18, 2025

Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.

Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.

Journal: International journal of cardiology

Published: April 09, 2025

Novel RNA-Based Therapies in the Management of Dyslipidemias.

Novel RNA-Based Therapies in the Management of Dyslipidemias.

Journal: International journal of molecular sciences

Published: December 11, 2024

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a).

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a).

Journal: Drugs in context

Published: October 04, 2024

Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis.

Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis.

Journal: Expert opinion on drug discovery

Published: May 28, 2024

Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?

Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?

Journal: Expert review of endocrinology & metabolism

Published: December 11, 2023

Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult.

Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult.

Journal: Diabetes research and clinical practice

Published: October 21, 2023

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).

Journal: International journal of molecular sciences

Published: August 08, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026